ZFN modified T cell (SB-313)
/ Sangamo Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 01, 2022
Off-the-shelf, Steroid Resistant, IL13Rα2-Specific CAR T Cells for Treatment of Glioblastoma.
(PubMed, Neuro Oncol)
- "This first-in-human experience establishes a foundation for future adoptive therapy studies using off-the-shelf, zinc-finger modified and/or glucocorticoid resistant CAR T cells."
CAR T-Cell Therapy • Journal • Brain Cancer • Glioblastoma • Immunology • Oncology • Solid Tumor • IL13 • IL13RA2 • IL2
March 12, 2020
"LIARS. You completely failed to support SB.3133, Conditional Approval, 5497, and 5480. You are a disaster! No wonder you dropped to a 3 star rating!"
(@als_now)
1 to 2
Of
2
Go to page
1